SPEAKER_1: Alright, so last time we covered the mechanics of SAFEs. Now, let's dive into the strategic negotiation aspects of term sheets. It's crucial to understand how to prioritize terms based on company goals rather than just fixating on the valuation number. SPEAKER_2: That fixation is exactly the trap. Instead, founders should focus on negotiation tactics that align with their long-term company goals. A term sheet is a non-binding summary — it's the starting point for final agreements, not the finish line. But the provisions buried inside it can reshape who controls the company and who profits from an exit. SPEAKER_1: Can you share some negotiation tactics for prioritizing terms based on company goals? SPEAKER_2: Founders should prioritize terms that align with their strategic goals. For instance, understanding how to negotiate board structure or protective provisions can significantly impact future decision-making and control. SPEAKER_1: Can you provide a case study of a successful negotiation that highlights these tactics? SPEAKER_2: Take liquidation preference. It dictates who gets paid first in an exit. A 1x non-participating preference means investors get their money back before founders see anything — but founders share the rest. A participating preference lets investors double-dip: they take their preference and then share the remaining proceeds. That structure can leave founders with almost nothing in a modest exit, even if the company sold for a healthy number. SPEAKER_1: And that's actually in seed term sheets? SPEAKER_2: Less than it used to be. Participating preferences dropped to just 12% inclusion in seed sheets by December 2025, per NVCA data — the market has shifted toward founder-friendly non-participating terms. But 12% still means one in eight deals. Our listener should know what they're looking at when it appears. SPEAKER_1: What about the option pool? That one seems to catch founders off guard. SPEAKER_2: It does, because it's framed as a benefit — shares reserved for future employees. But the option pool almost always dilutes founders, not investors, because it's carved out of the pre-money valuation. A 15% option pool on a $10M pre-money cap effectively reduces the founder's ownership before the investor's percentage is even calculated. Model it before signing. SPEAKER_1: So if I'm following — pre-money valuation sets the founder's dilution, post-money includes the new investment and shows what investors see as total value. But the option pool math sits inside the pre-money figure and quietly shrinks the founder's slice. SPEAKER_2: Exactly right. And that's why the 2025 NVCA survey finding matters here: 68% of seed term sheets now feature dynamic valuation caps that adjust to market benchmarks. That sounds sophisticated, but it also means the cap a founder negotiates today might not be the cap that governs conversion. Read the adjustment mechanism carefully. SPEAKER_1: What are the control provisions that actually have teeth? The ones that could block future funding rounds? SPEAKER_2: Three stand out. First, protective provisions — these give investors veto rights over major decisions like raising new capital, selling the company, or changing the business model. Second, drag-along rights, which can force minority shareholders to approve a sale. As of 2025, updated BVCA model documents set drag-along triggers at 50% shareholder approval, which is more founder-friendly than older versions. Third, redemption rights — these appeared in 8% of seed term sheets in 2025, the highest since 2010, driven by LP pressure. They can force a cash payout the startup simply can't afford. SPEAKER_1: Redemption rights at 8% — that feels like a red flag clause. How should someone negotiate around that? SPEAKER_2: Push for longer triggers or milestone-based waivers. A redemption right that activates in three years is very different from one that activates in seven. The goal is to make the timeline realistic relative to the company's growth trajectory. If an investor won't move on the trigger, that's signal about how they think about the relationship. SPEAKER_1: What about the no-shop clause? That's the exclusivity period, right? SPEAKER_2: Right — it's one of the few binding provisions in an otherwise non-binding document, along with confidentiality. No-shop periods averaged 45 days in Q1 2026 seed deals, up 20% from 2025 due to diligence complexity. That's 45 days a founder can't shop the deal elsewhere. If the investor walks, that's six weeks of momentum lost. Negotiate the length, and build in a clear termination trigger if diligence stalls. SPEAKER_1: There's also something happening on the format side — blockchain-based term sheets. Is that actually relevant yet? SPEAKER_2: It's early but real. As of April 2026, smart contract term sheets reduced negotiation time by 40% in about 15% of US seed rounds. The efficiency gain is genuine. But the legal enforceability is still being tested, so experienced startup counsel remains essential — that hasn't changed. SPEAKER_1: Speaking of counsel — how much of a term sheet is actually negotiable versus just standard? SPEAKER_2: More than founders assume, but less than they hope. Valuation, option pool size, board composition, pro-rata rights, and liquidation structure are all negotiable. The timeline — typically four to eight weeks from pitch to due diligence, one to two weeks of negotiation — is fairly standard. What's non-negotiable is the need to understand every clause before signing. Ignorance isn't leverage. SPEAKER_1: So for Test, and really for anyone navigating their first term sheet — what's the frame they should carry into that negotiation? SPEAKER_2: Term sheets have two categories of provisions: economic and control. Most founders fight over the economic terms and ignore the control terms — that's backwards. The provisions that determine whether a founder can raise their next round, keep their board seat, or actually profit from an exit live in the control column. Focus there first, model the dilution math before signing anything, and get counsel who's done this before. The valuation number is the headline. The control terms are the story.